In future years, more US patients will start treatment with Teva's migraine drug Ajovy.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Board chair at Coloplast and Lundbeck warns against large pay rises
Companies have a responsibility to help combat inflation by keeping pay rises in check during contract negotiations, says Lars Rasmussen.
Ellab slapped with customs fine over US imports
Danish medtech producer Ellab broke US customs rules and is now paying the price.
China approves Y-mabs drug
Y-mabs’ cancer treatment Danyelza, which is currently licensed to Sciclones, has been approved by the Chinese authorities. Y-mabs will receive double-digit sales royalties.
CEO gets "taste of own medicine" by participating in vaccine trial
Expres2ion CEO Bent U. Frandsen is one of 3,000 volunteers participating in a phase III trial of Bavarian Nordic’s Covid-19 booster candidate. If the vaccine reaches the market, Expres2ion will be entitled to royalties.
FDA approves Covid-19 jabs as boosters for infants
The US Food and Drug Administration has approved the use of Moderna and Pfizer/Biontech’s coronavirus vaccines as boosters for children as young as six months old.
Director, QA Commercial Drug Substance, Ascendis Pharma 
Medical Director 
Senior or Principal Scientist – Preclinical Biology 
Laboratory assistants for an exciting QC department 
Principal Systems Engineer 
Chief consultant for Dansk Erhvervs Health and life science 
Head of Regulatory Affairs Danmark 
Head of Engineering 
Quality Compliance Specialist - Herbal Medicines and Medical Devices 
Supply Chain Manager 
Consultants for FIERS - will you create unique healthcare collaborations? - FIERS - Copenhagen / Denmark